Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia (2017) 31 2 (318-324))

G. Montalban-Bravo, X. Huang, K. Naqvi, E. Jabbour, G. Borthakur, C. D. DiNardo, N. Pemmaraju, J. Cortes, S. Verstovsek, T. Kadia, N. Daver, W. Wierda, Y. Alvarado, M. Konopleva, F. Ravandi, Z. Estrov, N. Jain, A. Alfonso, M. Brandt, T. SneedH. C. Chen, H. Yang, C. Bueso-Ramos, S. Pierce, E. Estey, Z. Bohannan, H. M. Kantarjian, G. Garcia-Manero

Research output: Contribution to journalComment/debate

Abstract

This corrects the article DOI: 10.1038/leu.2016.303.

Original languageEnglish (US)
Number of pages1
JournalLeukemia
Volume31
Issue number7
DOIs
StatePublished - Jul 1 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia (2017) 31 2 (318-324))'. Together they form a unique fingerprint.

  • Cite this

    Montalban-Bravo, G., Huang, X., Naqvi, K., Jabbour, E., Borthakur, G., DiNardo, C. D., Pemmaraju, N., Cortes, J., Verstovsek, S., Kadia, T., Daver, N., Wierda, W., Alvarado, Y., Konopleva, M., Ravandi, F., Estrov, Z., Jain, N., Alfonso, A., Brandt, M., ... Garcia-Manero, G. (2017). Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia (2017) 31 2 (318-324)). Leukemia, 31(7). https://doi.org/10.1038/leu.2017.85